DNA Damaged Induced Cell Death in Oocytes
Abstract
:1. Introduction
2. Double-Strand Break Checkpoint
3. Evolutionary Conservation of Genetic Quality Control in Oocytes
4. Molecular Mechanism of Activation of TAp63α
5. Additional Activation Mechanisms
6. Other Family Members Involved in Oocyte Death
7. Chromosomal Synapsis Checkpoint
8. Chemotherapy-Induced Infertility in Female Cancer Patients
9. Fertility Mouse Experiments
10. Potential for Suppression of Oocyte Death during Chemotherapy
11. Conclusions
Funding
Conflicts of Interest
References
- Levine, A.J. p53: 800 million years of evolution and 40 years of discovery. Nat. Rev. Cancer 2020, 20, 471–480. [Google Scholar] [CrossRef] [PubMed]
- Vousden, K.H.; Lane, D.P. p53 in health and disease. Nat. Rev. 2007, 8, 275–283. [Google Scholar] [CrossRef]
- Vousden, K.H.; Prives, C. Blinded by the Light: The Growing Complexity of p53. Cell 2009, 137, 413–431. [Google Scholar] [CrossRef] [Green Version]
- Vousden, K.H.; Ryan, K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9, 691–700. [Google Scholar] [CrossRef]
- Lane, D.; Levine, A. p53 Research: The past thirty years and the next thirty years. Cold Spring Harb. Perspect. Biol. 2010, 2, a000893. [Google Scholar] [CrossRef] [Green Version]
- Joerger, A.C.; Fersht, A.R. The tumor suppressor p53: From structures to drug discovery. Cold Spring Harb. Perspect. Biol. 2010, 2, a000919. [Google Scholar] [CrossRef]
- Kouznetsova, A.; Wang, H.; Bellani, M.; Camerini-Otero, R.D.; Jessberger, R.; Hoog, C. BRCA1-mediated chromatin silencing is limited to oocytes with a small number of asynapsed chromosomes. J. Cell Sci. 2009, 122, 2446–2452. [Google Scholar] [CrossRef]
- Cloutier, J.M.; Mahadevaiah, S.K.; ElInati, E.; Nussenzweig, A.; Toth, A.; Turner, J.M. Histone H2AFX Links Meiotic Chromosome Asynapsis to Prophase I Oocyte Loss in Mammals. PLoS Genet. 2015, 11, e1005462. [Google Scholar] [CrossRef] [Green Version]
- Di Giacomo, M.; Barchi, M.; Baudat, F.; Edelmann, W.; Keeney, S.; Jasin, M. Distinct DNA-damage-dependent and -independent responses drive the loss of oocytes in recombination-defective mouse mutants. Proc. Natl. Acad. Sci. USA 2005, 102, 737–742. [Google Scholar] [CrossRef] [Green Version]
- Spears, N.; Lopes, F.; Stefansdottir, A.; Rossi, V.; De Felici, M.; Anderson, R.A.; Klinger, F.G. Ovarian damage from chemotherapy and current approaches to its protection. Hum. Reprod. Update 2019, 25, 673–693. [Google Scholar] [CrossRef]
- Balcerek, M.; Reinmuth, S.; Hohmann, C.; Keil, T.; Borgmann-Staudt, A. Suspected infertility after treatment for leukemia and solid tumors in childhood and adolescence. Dtsch. Arztebl. Int. 2012, 109, 126–131. [Google Scholar] [CrossRef]
- Hao, X.; Anastacio, A.; Liu, K.; Rodriguez-Wallberg, K.A. Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments-A Review. Int. J. Mol. Sci. 2019, 20, 4720. [Google Scholar] [CrossRef] [Green Version]
- Jeruss, J.S.; Woodruff, T.K. Preservation of fertility in patients with cancer. N. Engl. J. Med. 2009, 360, 902–911. [Google Scholar] [CrossRef] [Green Version]
- Johnston, R.J.; Wallace, W.H. Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer. Pediatr. Blood Cancer 2009, 53, 296–302. [Google Scholar] [CrossRef]
- Maltaris, T.; Beckmann, M.W.; Dittrich, R. Review. Fertility preservation for young female cancer patients. Vivo 2009, 23, 123–130. [Google Scholar]
- Keeney, S.; Giroux, C.N.; Kleckner, N. Meiosis-specific DNA double-strand breaks are catalyzed by Spo11, a member of a widely conserved protein family. Cell 1997, 88, 375–384. [Google Scholar] [CrossRef] [Green Version]
- Romanienko, P.J.; Camerini-Otero, R.D. The mouse Spo11 gene is required for meiotic chromosome synapsis. Mol. Cell 2000, 6, 975–987. [Google Scholar] [CrossRef]
- Hinch, A.G.; Becker, P.W.; Li, T.; Moralli, D.; Zhang, G.; Bycroft, C.; Green, C.; Keeney, S.; Shi, Q.; Davies, B.; et al. The Configuration of RPA, RAD51, and DMC1 Binding in Meiosis Reveals the Nature of Critical Recombination Intermediates. Mol. Cell 2020, 79, 689–701.e60. [Google Scholar] [CrossRef]
- Eppig, J.J. Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. Reprod. Fertil. Dev. 1996, 8, 485–489. [Google Scholar] [CrossRef]
- Suh, E.K.; Yang, A.; Kettenbach, A.; Bamberger, C.; Michaelis, A.H.; Zhu, Z.; Elvin, J.A.; Bronson, R.T.; Crum, C.P.; McKeon, F. p63 protects the female germ line during meiotic arrest. Nature 2006, 444, 624–628. [Google Scholar] [CrossRef]
- Livera, G.; Petre-Lazar, B.; Guerquin, M.J.; Trautmann, E.; Coffigny, H.; Habert, R. p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction 2008, 135, 3–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, A.; Kaghad, M.; Wang, Y.; Gillett, E.; Fleming, M.D.; Dotsch, V.; Andrews, N.C.; Caput, D.; McKeon, F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 1998, 2, 305–316. [Google Scholar] [CrossRef]
- Straub, W.E.; Weber, T.A.; Schafer, B.; Candi, E.; Durst, F.; Ou, H.D.; Rajalingam, K.; Melino, G.; Dotsch, V. The C-terminus of p63 contains multiple regulatory elements with different functions. Cell Death Dis. 2010, 1, e5. [Google Scholar] [CrossRef]
- Fisher, M.L.; Balinth, S.; Mills, A.A. p63-related signaling at a glance. J. Cell Sci. 2020, 133, jcs228015. [Google Scholar] [CrossRef] [PubMed]
- Kim, D.A.; Suh, E.K. Defying DNA double-strand break-induced death during prophase I meiosis by temporal TAp63alpha phosphorylation regulation in developing mouse oocytes. Mol. Cell. Biol. 2014, 34, 1460–1473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Block, E. Quantitative morphological investigations of the follicular system in women; variations at different ages. Acta Anat. 1952, 14, 108–123. [Google Scholar] [CrossRef] [PubMed]
- Block, E. A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat. 1953, 17, 201–206. [Google Scholar] [CrossRef]
- Malki, S.; van der Heijden, G.W.; O’Donnell, K.A.; Martin, S.L.; Bortvin, A. A role for retrotransposon LINE-1 in fetal oocyte attrition in mice. Dev. Cell 2014, 29, 521–533. [Google Scholar] [CrossRef] [Green Version]
- Kerr, J.B.; Hutt, K.J.; Michalak, E.M.; Cook, M.; Vandenberg, C.J.; Liew, S.H.; Bouillet, P.; Mills, A.; Scott, C.L.; Findlay, J.K.; et al. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa. Mol. Cell 2012, 48, 343–352. [Google Scholar] [CrossRef] [Green Version]
- Youle, R.J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. 2008, 9, 47–59. [Google Scholar] [CrossRef]
- Willis, S.N.; Fletcher, J.I.; Kaufmann, T.; van Delft, M.F.; Chen, L.; Czabotar, P.E.; Ierino, H.; Lee, E.F.; Fairlie, W.D.; Bouillet, P.; et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007, 315, 856–859. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nguyen, Q.N.; Zerafa, N.; Liew, S.H.; Morgan, F.H.; Strasser, A.; Scott, C.L.; Findlay, J.K.; Hickey, M.; Hutt, K.J. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility. Cell Death Dis. 2018, 9, 618. [Google Scholar] [CrossRef] [PubMed]
- ElInati, E.; Zielinska, A.P.; McCarthy, A.; Kubikova, N.; Maciulyte, V.; Mahadevaiah, S.; Sangrithi, M.N.; Ojarikre, O.; Wells, D.; Niakan, K.K.; et al. The BCL-2 pathway preserves mammalian genome integrity by eliminating recombination-defective oocytes. Nat. Commun. 2020, 11, 2598. [Google Scholar] [CrossRef] [PubMed]
- Ou, H.D.; Lohr, F.; Vogel, V.; Mantele, W.; Dotsch, V. Structural evolution of C-terminal domains in the p53 family. EMBO J. 2007, 26, 3463–3473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ou, H.L.; Schumacher, B. DNA damage responses and p53 in the aging process. Blood 2018, 131, 488–495. [Google Scholar] [CrossRef] [Green Version]
- Ou, H.L.; Kim, C.S.; Uszkoreit, S.; Wickstrom, S.A.; Schumacher, B. Somatic Niche Cells Regulate the CEP-1/p53-Mediated DNA Damage Response in Primordial Germ Cells. Dev. Cell 2019, 50, 167–183.e8. [Google Scholar] [CrossRef]
- Derry, W.B.; Putzke, A.P.; Rothman, J.H. Caenorhabditis elegans p53: Role in apoptosis, meiosis, and stress resistance. Science 2001, 294, 591–595. [Google Scholar] [CrossRef] [Green Version]
- Schumacher, B.; Hofmann, K.; Boulton, S.; Gartner, A. The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Curr. Biol. 2001, 11, 1722–1727. [Google Scholar] [CrossRef] [Green Version]
- Schumacher, B.; Hanazawa, M.; Lee, M.H.; Nayak, S.; Volkmann, K.; Hofmann, E.R.; Hengartner, M.; Schedl, T.; Gartner, A. Translational repression of C. elegans p53 by GLD-1 regulates DNA damage-induced apoptosis. Cell 2005, 120, 357–368. [Google Scholar] [CrossRef] [Green Version]
- Hofmann, E.R.; Milstein, S.; Boulton, S.J.; Ye, M.; Hofmann, J.J.; Stergiou, L.; Gartner, A.; Vidal, M.; Hengartner, M.O. Caenorhabditis elegans HUS-1 is a DNA damage checkpoint protein required for genome stability and EGL-1-mediated apoptosis. Curr. Biol. 2002, 12, 1908–1918. [Google Scholar] [CrossRef] [Green Version]
- Schumacher, B.; Schertel, C.; Wittenburg, N.; Tuck, S.; Mitani, S.; Gartner, A.; Conradt, B.; Shaham, S.C. elegans ced-13 can promote apoptosis and is induced in response to DNA damage. Cell Death Differ. 2005, 12, 153–161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ackermann, L.; Schell, M.; Pokrzywa, W.; Kevei, E.; Gartner, A.; Schumacher, B.; Hoppe, T. E4 ligase-specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosis. Nat. Struct. Mol. Biol. 2016, 23, 995–1002. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gao, M.X.; Liao, E.H.; Yu, B.; Wang, Y.; Zhen, M.; Derry, W.B. The SCF FSN-1 ubiquitin ligase controls germline apoptosis through CEP-1/p53 in C. elegans. Cell Death Differ. 2008, 15, 1054–1062. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fernandez-Majada, V.; Welz, P.S.; Ermolaeva, M.A.; Schell, M.; Adam, A.; Dietlein, F.; Komander, D.; Buttner, R.; Thomas, R.K.; Schumacher, B.; et al. The tumour suppressor CYLD regulates the p53 DNA damage response. Nat. Commun. 2016, 7, 12508. [Google Scholar] [CrossRef]
- Perrin, A.J.; Gunda, M.; Yu, B.; Yen, K.; Ito, S.; Forster, S.; Tissenbaum, H.A.; Derry, W.B. Noncanonical control of C. elegans germline apoptosis by the insulin/IGF-1 and Ras/MAPK signaling pathways. Cell Death Differ. 2013, 20, 97–107. [Google Scholar] [CrossRef] [Green Version]
- Rutkowski, R.; Dickinson, R.; Stewart, G.; Craig, A.; Schimpl, M.; Keyse, S.M.; Gartner, A. Regulation of Caenorhabditis elegans p53/CEP-1-dependent germ cell apoptosis by Ras/MAPK signaling. PLoS Genet. 2011, 7, e1002238. [Google Scholar] [CrossRef] [Green Version]
- Doll, M.A.; Soltanmohammadi, N.; Schumacher, B. ALG-2/AGO-Dependent mir-35 Family Regulates DNA Damage-Induced Apoptosis Through MPK-1/ERK MAPK Signaling Downstream of the Core Apoptotic Machinery in Caenorhabditis elegans. Genetics 2019, 213, 173–194. [Google Scholar] [CrossRef]
- Ollmann, M.; Young, L.M.; Di Como, C.J.; Karim, F.; Belvin, M.; Robertson, S.; Whittaker, K.; Demsky, M.; Fisher, W.W.; Buchman, A.; et al. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 2000, 101, 91–101. [Google Scholar] [CrossRef] [Green Version]
- Brodsky, M.H.; Nordstrom, W.; Tsang, G.; Kwan, E.; Rubin, G.M.; Abrams, J.M. Drosophila p53 binds a damage response element at the reaper locus. Cell 2000, 101, 103–113. [Google Scholar] [CrossRef] [Green Version]
- Jin, S.; Martinek, S.; Joo, W.S.; Wortman, J.R.; Mirkovic, N.; Sali, A.; Yandell, M.D.; Pavletich, N.P.; Young, M.W.; Levine, A.J. Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 2000, 97, 7301–7306. [Google Scholar] [CrossRef] [Green Version]
- Zhang, B.; Rotelli, M.; Dixon, M.; Calvi, B.R. The function of Drosophila p53 isoforms in apoptosis. Cell Death Differ. 2015, 22, 2058–2067. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jassim, O.W.; Fink, J.L.; Cagan, R.L. Dmp53 protects the Drosophila retina during a developmentally regulated DNA damage response. EMBO J. 2003, 22, 5622–5632. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fan, Y.; Lee, T.V.; Xu, D.; Chen, Z.; Lamblin, A.F.; Steller, H.; Bergmann, A. Dual roles of Drosophila p53 in cell death and cell differentiation. Cell Death Differ. 2010, 17, 912–921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yamada, Y.; Davis, K.D.; Coffman, C.R. Programmed cell death of primordial germ cells in Drosophila is regulated by p53 and the Outsiders monocarboxylate transporter. Development 2008, 135, 207–216. [Google Scholar] [CrossRef] [Green Version]
- Lu, W.J.; Chapo, J.; Roig, I.; Abrams, J.M. Meiotic recombination provokes functional activation of the p53 regulatory network. Science 2010, 328, 1278–1281. [Google Scholar] [CrossRef] [Green Version]
- Wylie, A.; Lu, W.J.; D’Brot, A.; Buszczak, M.; Abrams, J.M. p53 activity is selectively licensed in the Drosophila stem cell compartment. Elife 2014, 3, e01530. [Google Scholar] [CrossRef]
- Brodsky, M.H.; Weinert, B.T.; Tsang, G.; Rong, Y.S.; McGinnis, N.M.; Golic, K.G.; Rio, D.C.; Rubin, G.M. Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage. Mol. Cell. Biol. 2004, 24, 1219–1231. [Google Scholar] [CrossRef] [Green Version]
- Peters, M.; DeLuca, C.; Hirao, A.; Stambolic, V.; Potter, J.; Zhou, L.; Liepa, J.; Snow, B.; Arya, S.; Wong, J.; et al. Chk2 regulates irradiation-induced, p53-mediated apoptosis in Drosophila. Proc. Natl. Acad. Sci. USA 2002, 99, 11305–11310. [Google Scholar] [CrossRef] [Green Version]
- Deutsch, G.B.; Zielonka, E.M.; Coutandin, D.; Weber, T.A.; Schafer, B.; Hannewald, J.; Luh, L.M.; Durst, F.G.; Ibrahim, M.; Hoffmann, J.; et al. DNA damage in oocytes induces a switch of the quality control factor TAp63alpha from dimer to tetramer. Cell 2011, 144, 566–576. [Google Scholar] [CrossRef] [Green Version]
- Jeffrey, P.D.; Gorina, S.; Pavletich, N.P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 1995, 267, 1498–1502. [Google Scholar] [CrossRef]
- Lee, W.; Harvey, T.S.; Yin, Y.; Yau, P.; Litchfield, D.; Arrowsmith, C.H. Solution structure of the tetrameric minimum transforming domain of p53. Nat. Struct. Biol. 1994, 1, 877–890. [Google Scholar] [CrossRef] [PubMed]
- Coutandin, D.; Lohr, F.; Niesen, F.H.; Ikeya, T.; Weber, T.A.; Schafer, B.; Zielonka, E.M.; Bullock, A.N.; Yang, A.; Guntert, P.; et al. Conformational stability and activity of p73 require a second helix in the tetramerization domain. Cell Death Differ. 2009, 16, 1582–1589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Joerger, A.C.; Rajagopalan, S.; Natan, E.; Veprintsev, D.B.; Robinson, C.V.; Fersht, A.R. Structural evolution of p53, p63, and p73: Implication for heterotetramer formation. Proc. Natl. Acad. Sci. USA 2009, 106, 17705–17710. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Coutandin, D.; Osterburg, C.; Srivastav, R.K.; Sumyk, M.; Kehrloesser, S.; Gebel, J.; Tuppi, M.; Hannewald, J.; Schafer, B.; Salah, E.; et al. Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level. Elife 2016, 5, e13909. [Google Scholar] [CrossRef]
- Serber, Z.; Lai, H.C.; Yang, A.; Ou, H.D.; Sigal, M.S.; Kelly, A.E.; Darimont, B.D.; Duijf, P.H.; Van Bokhoven, H.; McKeon, F.; et al. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism. Mol. Cell. Biol. 2002, 22, 8601–8611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Krois, A.S.; Ferreon, J.C.; Martinez-Yamout, M.A.; Dyson, H.J.; Wright, P.E. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein. Proc. Natl. Acad. Sci. USA 2016, 113, E1853–E1862. [Google Scholar] [CrossRef] [Green Version]
- Burge, S.; Teufel, D.P.; Townsley, F.M.; Freund, S.M.; Bycroft, M.; Fersht, A.R. Molecular basis of the interactions between the p73 N terminus and p300: Effects on transactivation and modulation by phosphorylation. Proc. Natl. Acad. Sci. USA 2009, 106, 3142–3147. [Google Scholar] [CrossRef] [Green Version]
- Luh, L.M.; Kehrloesser, S.; Deutsch, G.B.; Gebel, J.; Coutandin, D.; Schafer, B.; Agostini, M.; Melino, G.; Dotsch, V. Analysis of the oligomeric state and transactivation potential of TAp73alpha. Cell Death Differ. 2013, 20, 1008–1016. [Google Scholar] [CrossRef]
- Krauskopf, K.; Gebel, J.; Kazemi, S.; Tuppi, M.; Lohr, F.; Schafer, B.; Koch, J.; Guntert, P.; Dotsch, V.; Kehrloesser, S. Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain. Structure 2018, 26, 1091–1100.e4. [Google Scholar] [CrossRef] [Green Version]
- Hirao, A.; Cheung, A.; Duncan, G.; Girard, P.M.; Elia, A.J.; Wakeham, A.; Okada, H.; Sarkissian, T.; Wong, J.A.; Sakai, T.; et al. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol. Cell. Biol. 2002, 22, 6521–6532. [Google Scholar] [CrossRef] [Green Version]
- Bolcun-Filas, E.; Rinaldi, V.D.; White, M.E.; Schimenti, J.C. Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. Science 2014, 343, 533–536. [Google Scholar] [CrossRef] [Green Version]
- Tuppi, M.; Kehrloesser, S.; Coutandin, D.W.; Rossi, V.; Luh, L.M.; Strubel, A.; Hotte, K.; Hoffmeister, M.; Schafer, B.; De Oliveira, T.; et al. Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63. Nat. Struct. Mol. Biol. 2018, 25, 261–269. [Google Scholar] [CrossRef]
- Flotow, H.; Graves, P.R.; Wang, A.Q.; Fiol, C.J.; Roeske, R.W.; Roach, P.J. Phosphate groups as substrate determinants for casein kinase I action. J. Biol. Chem. 1990, 265, 14264–14269. [Google Scholar]
- Cesaro, L.; Pinna, L.A. The generation of phosphoserine stretches in phosphoproteins: Mechanism and significance. Mol. Biosyst. 2015, 11, 2666–2679. [Google Scholar] [CrossRef]
- Gebel, J.; Tuppi, M.; Chaikuad, A.; Hotte, K.; Schroder, M.; Schulz, L.; Lohr, F.; Gutfreund, N.; Finke, F.; Henrich, E.; et al. p63 uses a switch-like mechanism to set the threshold for induction of apoptosis. Nat. Chem. Biol. 2020, 16, 1078–1086. [Google Scholar] [CrossRef]
- Deutsch, G.B.; Zielonka, E.M.; Coutandin, D.; Dotsch, V. Quality control in oocytes: Domain-domain interactions regulate the activity of p63. Cell Cycle 2011, 10, 1884–1885. [Google Scholar] [CrossRef]
- Guazzarotti, L.; Caprio, C.; Rinne, T.K.; Bosoni, M.; Pattarino, G.; Mauri, S.; Tadini, G.L.; van Bokhoven, H.; Zuccotti, G.V. Limb-mammary syndrome (LMS) associated with internal female genitalia dysgenesia: A new genotype/phenotype correlation? Am. J. Med. Genet. 2008, 146A, 2001–2004. [Google Scholar] [CrossRef]
- Mathorne, S.W.; Ravn, P.; Hansen, D.; Beck-Nielsen, S.S.; Gjorup, H.; Sorensen, K.P.; Fagerberg, C.R. Novel phenotype of syndromic premature ovarian insufficiency associated with TP63 molecular defect. Clin. Genet. 2020, 97, 779–784. [Google Scholar] [CrossRef]
- Holder-Espinasse, M.; Martin-Coignard, D.; Escande, F.; Manouvrier-Hanu, S. A new mutation in TP63 is associated with age-related pathology. Eur. J. Hum. Genet. 2007, 15, 1115–1120. [Google Scholar] [CrossRef]
- Tucker, E.J.; Grover, S.R.; Robevska, G.; van den Bergen, J.; Hanna, C.; Sinclair, A.H. Identification of variants in pleiotropic genes causing “isolated” premature ovarian insufficiency: Implications for medical practice. Eur. J. Hum. Genet. 2018, 26, 1319–1328. [Google Scholar] [CrossRef] [Green Version]
- Tucker, E.J.; Jaillard, S.; Grover, S.R.; van den Bergen, J.; Robevska, G.; Bell, K.M.; Sadedin, S.; Hanna, C.; Dulon, J.; Touraine, P.; et al. TP63-truncating variants cause isolated premature ovarian insufficiency. Hum. Mutat. 2019, 40, 886–892. [Google Scholar] [CrossRef]
- Bestetti, I.; Castronovo, C.; Sironi, A.; Caslini, C.; Sala, C.; Rossetti, R.; Crippa, M.; Ferrari, I.; Pistocchi, A.; Toniolo, D.; et al. High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function. Hum. Reprod. 2019, 34, 574–583. [Google Scholar] [CrossRef]
- Celli, J.; Duijf, P.; Hamel, B.C.; Bamshad, M.; Kramer, B.; Smits, A.P.; Newbury-Ecob, R.; Hennekam, R.C.; Van Buggenhout, G.; van Haeringen, A.; et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999, 99, 143–153. [Google Scholar] [CrossRef] [Green Version]
- Brunner, H.G.; Hamel, B.C.; Van Bokhoven, H. The p63 gene in EEC and other syndromes. J. Med. Genet. 2002, 39, 377–381. [Google Scholar] [CrossRef] [Green Version]
- Barrow, L.L.; van Bokhoven, H.; Daack-Hirsch, S.; Andersen, T.; van Beersum, S.E.; Gorlin, R.; Murray, J.C. Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts. J. Med. Genet. 2002, 39, 559–566. [Google Scholar] [CrossRef] [Green Version]
- Duijf, P.H.; Vanmolkot, K.R.; Propping, P.; Friedl, W.; Krieger, E.; McKeon, F.; Dotsch, V.; Brunner, H.G.; van Bokhoven, H. Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63. Hum. Mol. Genet. 2002, 11, 799–804. [Google Scholar] [CrossRef]
- Rinne, T.; Bolat, E.; Meijer, R.; Scheffer, H.; van Bokhoven, H. Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC). Am. J. Med. Genet. 2009, 149A, 1948–1951. [Google Scholar] [CrossRef]
- McGrath, J.A.; Duijf, P.H.; Doetsch, V.; Irvine, A.D.; de Waal, R.; Vanmolkot, K.R.; Wessagowit, V.; Kelly, A.; Atherton, D.J.; Griffiths, W.A.; et al. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum. Mol. Genet. 2001, 10, 221–229. [Google Scholar] [CrossRef] [Green Version]
- Browne, G.; Cipollone, R.; Lena, A.M.; Serra, V.; Zhou, H.; van Bokhoven, H.; Dotsch, V.; Merico, D.; Mantovani, R.; Terrinoni, A.; et al. Differential altered stability and transcriptional activity of DeltaNp63 mutants in distinct ectodermal dysplasias. J. Cell Sci. 2011, 124, 2200–2207. [Google Scholar] [CrossRef] [Green Version]
- Russo, C.; Osterburg, C.; Sirico, A.; Antonini, D.; Ambrosio, R.; Wurz, J.M.; Rinnenthal, J.; Ferniani, M.; Kehrloesser, S.; Schafer, B.; et al. Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome. Proc. Natl. Acad. Sci. USA 2018, 115, E906–E915. [Google Scholar] [CrossRef] [Green Version]
- Kim, S.Y.; Nair, D.M.; Romero, M.; Serna, V.A.; Koleske, A.J.; Woodruff, T.K.; Kurita, T. Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies. Cell Death Differ. 2019, 26, 502–515. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rinaldi, V.D.; Bloom, J.C.; Schimenti, J.C. Oocyte Elimination Through DNA Damage Signaling from CHK1/CHK2 to p53 and p63. Genetics 2020, 215, 373–378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Luan, Y.; Edmonds, M.E.; Woodruff, T.K.; Kim, S.Y. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J. Endocrinol. 2019, 240, 243–256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, X.Q.; Redpath, J.L.; Fan, S.T.; Stanbridge, E.J. ATR dependent activation of Chk2. J. Cell. Physiol. 2006, 208, 613–619. [Google Scholar] [CrossRef]
- Gonfloni, S.; Di Tella, L.; Caldarola, S.; Cannata, S.M.; Klinger, F.G.; Di Bartolomeo, C.; Mattei, M.; Candi, E.; De Felici, M.; Melino, G.; et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat. Med. 2009, 15, 1179–1185. [Google Scholar] [CrossRef]
- Bildik, G.; Acilan, C.; Sahin, G.N.; Karahuseyinoglu, S.; Oktem, O. C-Abl is not activated in DNA damage-induced and Tap63-mediated oocyte apoptosis in human ovary. Cell Death Dis. 2018, 9, 943. [Google Scholar] [CrossRef]
- Senoo, M.; Pinto, F.; Crum, C.P.; McKeon, F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007, 129, 523–536. [Google Scholar] [CrossRef] [Green Version]
- Yang, A.; Schweitzer, R.; Sun, D.; Kaghad, M.; Walker, N.; Bronson, R.T.; Tabin, C.; Sharpe, A.; Caput, D.; Crum, C.; et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398, 714–718. [Google Scholar] [CrossRef]
- Mills, A.A.; Zheng, B.; Wang, X.J.; Vogel, H.; Roop, D.R.; Bradley, A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999, 398, 708–713. [Google Scholar] [CrossRef]
- Stringer, J.M.; Winship, A.; Zerafa, N.; Wakefield, M.; Hutt, K. Oocytes can efficiently repair DNA double-strand breaks to restore genetic integrity and protect offspring health. Proc. Natl. Acad. Sci. USA 2020, 117, 11513–11522. [Google Scholar] [CrossRef]
- Perez, G.I.; Knudson, C.M.; Leykin, L.; Korsmeyer, S.J.; Tilly, J.L. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat. Med. 1997, 3, 1228–1232. [Google Scholar] [CrossRef] [PubMed]
- Yang, A.; Walker, N.; Bronson, R.; Kaghad, M.; Oosterwegel, M.; Bonnin, J.; Vagner, C.; Bonnet, H.; Dikkes, P.; Sharpe, A.; et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000, 404, 99–103. [Google Scholar] [CrossRef]
- Marshall, C.B.; Mays, D.J.; Beeler, J.S.; Rosenbluth, J.M.; Boyd, K.L.; Santos Guasch, G.L.; Shaver, T.M.; Tang, L.J.; Liu, Q.; Shyr, Y.; et al. p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network. Cell Rep. 2016, 14, 2289–2300. [Google Scholar] [CrossRef] [Green Version]
- Nemajerova, A.; Amelio, I.; Gebel, J.; Dotsch, V.; Melino, G.; Moll, U.M. Non-oncogenic roles of TAp73: From multiciliogenesis to metabolism. Cell Death Differ. 2018, 25, 144–153. [Google Scholar] [CrossRef] [PubMed]
- Tomasini, R.; Tsuchihara, K.; Wilhelm, M.; Fujitani, M.; Rufini, A.; Cheung, C.C.; Khan, F.; Itie-Youten, A.; Wakeham, A.; Tsao, M.S.; et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev. 2008, 22, 2677–2691. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tomasini, R.; Tsuchihara, K.; Tsuda, C.; Lau, S.K.; Wilhelm, M.; Rufini, A.; Tsao, M.S.; Iovanna, J.L.; Jurisicova, A.; Melino, G.; et al. TAp73 regulates the spindle assembly checkpoint by modulating BubR1 activity. Proc. Natl. Acad. Sci. USA 2009, 106, 797–802. [Google Scholar] [CrossRef] [Green Version]
- Kim, S.Y.; Cordeiro, M.H.; Serna, V.A.; Ebbert, K.; Butler, L.M.; Sinha, S.; Mills, A.A.; Woodruff, T.K.; Kurita, T. Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network. Cell Death Differ. 2013, 20, 987–997. [Google Scholar] [CrossRef] [Green Version]
- Hutt, K.; Kerr, J.B.; Scott, C.L.; Findlay, J.K.; Strasser, A. How to best preserve oocytes in female cancer patients exposed to DNA damage inducing therapeutics. Cell Death Differ. 2013, 20, 967–968. [Google Scholar] [CrossRef] [Green Version]
- Hunter, N.; Kleckner, N. The single-end invasion: An asymmetric intermediate at the double-strand break to double-holliday junction transition of meiotic recombination. Cell 2001, 106, 59–70. [Google Scholar] [CrossRef] [Green Version]
- Hunter, N. Meiotic Recombination: The Essence of Heredity. Cold Spring Harb. Perspect. Biol. 2015, 7, a016618. [Google Scholar] [CrossRef] [Green Version]
- Wang, S.; Hassold, T.; Hunt, P.; White, M.A.; Zickler, D.; Kleckner, N.; Zhang, L. Inefficient Crossover Maturation Underlies Elevated Aneuploidy in Human Female Meiosis. Cell 2017, 168, 977–989.e17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Golin, J.E.; Esposito, M.S. Mitotic recombination: Mismatch correction and replicational resolution of Holliday structures formed at the two strand stage in Saccharomyces. Mol. Gen. Genet. 1981, 183, 252–263. [Google Scholar] [CrossRef] [PubMed]
- Hawley, R.S. Human meiosis: Model organisms address the maternal age effect. Curr. Biol. 2003, 13, R305–R307. [Google Scholar] [CrossRef] [Green Version]
- Jeffreys, C.A.; Burrage, P.S.; Bickel, S.E. A model system for increased meiotic nondisjunction in older oocytes. Curr. Biol. 2003, 13, 498–503. [Google Scholar] [CrossRef] [Green Version]
- Ottolini, C.S.; Newnham, L.; Capalbo, A.; Natesan, S.A.; Joshi, H.A.; Cimadomo, D.; Griffin, D.K.; Sage, K.; Summers, M.C.; Thornhill, A.R.; et al. Genome-wide maps of recombination and chromosome segregation in human oocytes and embryos show selection for maternal recombination rates. Nat. Genet. 2015, 47, 727–735. [Google Scholar] [CrossRef] [Green Version]
- Carofiglio, F.; Inagaki, A.; de Vries, S.; Wassenaar, E.; Schoenmakers, S.; Vermeulen, C.; van Cappellen, W.A.; Sleddens-Linkels, E.; Grootegoed, J.A.; Te Riele, H.P.; et al. SPO11-independent DNA repair foci and their role in meiotic silencing. PLoS Genet. 2013, 9, e1003538. [Google Scholar] [CrossRef] [Green Version]
- Wojtasz, L.; Daniel, K.; Roig, I.; Bolcun-Filas, E.; Xu, H.; Boonsanay, V.; Eckmann, C.R.; Cooke, H.J.; Jasin, M.; Keeney, S.; et al. Mouse HORMAD1 and HORMAD2, two conserved meiotic chromosomal proteins, are depleted from synapsed chromosome axes with the help of TRIP13 AAA-ATPase. PLoS Genet. 2009, 5, e1000702. [Google Scholar] [CrossRef] [Green Version]
- Daniel, K.; Lange, J.; Hached, K.; Fu, J.; Anastassiadis, K.; Roig, I.; Cooke, H.J.; Stewart, A.F.; Wassmann, K.; Jasin, M.; et al. Meiotic homologue alignment and its quality surveillance are controlled by mouse HORMAD1. Nat. Cell Biol. 2011, 13, 599–610. [Google Scholar] [CrossRef] [Green Version]
- Kogo, H.; Tsutsumi, M.; Ohye, T.; Inagaki, H.; Abe, T.; Kurahashi, H. HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes. Genes Cells 2012, 17, 439–454. [Google Scholar] [CrossRef]
- Rinaldi, V.D.; Bolcun-Filas, E.; Kogo, H.; Kurahashi, H.; Schimenti, J.C. The DNA Damage Checkpoint Eliminates Mouse Oocytes with Chromosome Synapsis Failure. Mol. Cell 2017, 67, 1026–1036.e2. [Google Scholar] [CrossRef] [Green Version]
- Carballo, J.A.; Johnson, A.L.; Sedgwick, S.G.; Cha, R.S. Phosphorylation of the axial element protein Hop1 by Mec1/Tel1 ensures meiotic interhomolog recombination. Cell 2008, 132, 758–770. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Royo, H.; Prosser, H.; Ruzankina, Y.; Mahadevaiah, S.K.; Cloutier, J.M.; Baumann, M.; Fukuda, T.; Hoog, C.; Toth, A.; de Rooij, D.G.; et al. ATR acts stage specifically to regulate multiple aspects of mammalian meiotic silencing. Genes Dev. 2013, 27, 1484–1494. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shin, Y.H.; McGuire, M.M.; Rajkovic, A. Mouse HORMAD1 is a meiosis i checkpoint protein that modulates DNA double- strand break repair during female meiosis. Biol. Reprod. 2013, 89, 29. [Google Scholar] [CrossRef] [PubMed]
- Stanzione, M.; Baumann, M.; Papanikos, F.; Dereli, I.; Lange, J.; Ramlal, A.; Trankner, D.; Shibuya, H.; de Massy, B.; Watanabe, Y.; et al. Meiotic DNA break formation requires the unsynapsed chromosome axis-binding protein IHO1 (CCDC36) in mice. Nat. Cell Biol. 2016, 18, 1208–1220. [Google Scholar] [CrossRef] [PubMed]
- Qiao, H.; Rao, H.; Yun, Y.; Sandhu, S.; Fong, J.H.; Sapre, M.; Nguyen, M.; Tham, A.; Van, B.W.; Chng, T.Y.H.; et al. Impeding DNA Break Repair Enables Oocyte Quality Control. Mol. Cell 2018, 72, 211–221.e3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wallace, W.H.; Thomson, A.B.; Kelsey, T.W. The radiosensitivity of the human oocyte. Hum. Reprod. 2003, 18, 117–121. [Google Scholar] [CrossRef] [Green Version]
- Quast, U. Whole body radiotherapy: A TBI-guideline. J. Med. Phys. 2006, 31, 5–12. [Google Scholar] [CrossRef]
- Wallace, W.H.; Thomson, A.B.; Saran, F.; Kelsey, T.W. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62, 738–744. [Google Scholar] [CrossRef]
- Peate, M.; Meiser, B.; Hickey, M.; Friedlander, M. The fertility-related concerns, needs and preferences of younger women with breast cancer: A systematic review. Breast Cancer Res. Treat. 2009, 116, 215–223. [Google Scholar] [CrossRef]
- van Dorp, W.; Haupt, R.; Anderson, R.A.; Mulder, R.L.; van den Heuvel-Eibrink, M.M.; van Dulmen-den Broeder, E.; Su, H.I.; Winther, J.F.; Hudson, M.M.; Levine, J.M.; et al. Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review. J. Clin. Oncol. 2018, 36, 2169–2180. [Google Scholar] [CrossRef]
- Green, D.M.; Sklar, C.A.; Boice, J.D., Jr.; Mulvihill, J.J.; Whitton, J.A.; Stovall, M.; Yasui, Y. Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2009, 27, 2374–2381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reinmuth, S.; Hohmann, C.; Rendtorff, R.; Balcerek, M.; Holzhausen, S.; Muller, A.; Henze, G.; Keil, T.; Borgmann-Staudt, A. Impact of chemotherapy and radiotherapy in childhood on fertility in adulthood: The FeCt-survey of childhood cancer survivors in Germany. J. Cancer Res. Clin. Oncol. 2013, 139, 2071–2078. [Google Scholar] [CrossRef] [PubMed]
- Wallace, W.H.; Anderson, R.A.; Irvine, D.S. Fertility preservation for young patients with cancer: Who is at risk and what can be offered? Lancet Oncol. 2005, 6, 209–218. [Google Scholar] [CrossRef]
- Donnez, J.; Dolmans, M.M. Fertility Preservation in Women. N. Engl. J. Med. 2017, 377, 1657–1665. [Google Scholar] [CrossRef] [PubMed]
- Pitzius, S.; Osterburg, C.; Gebel, J.; Tascher, G.; Schafer, B.; Zhou, H.; Munch, C.; Dotsch, V. TA*p63 and GTAp63 achieve tighter transcriptional regulation in quality control by converting an inhibitory element into an additional transactivation domain. Cell Death Dis. 2019, 10, 686. [Google Scholar] [CrossRef] [Green Version]
- Rinaldi, V.D.; Hsieh, K.; Munroe, R.; Bolcun-Filas, E.; Schimenti, J.C. Pharmacological Inhibition of the DNA Damage Checkpoint Prevents Radiation-Induced Oocyte Death. Genetics 2017, 206, 1823–1828. [Google Scholar] [CrossRef] [Green Version]
- Sehorn, M.G.; Sigurdsson, S.; Bussen, W.; Unger, V.M.; Sung, P. Human meiotic recombinase Dmc1 promotes ATP-dependent homologous DNA strand exchange. Nature 2004, 429, 433–437. [Google Scholar] [CrossRef]
- Bishop, D.K.; Park, D.; Xu, L.; Kleckner, N. DMC1: A meiosis-specific yeast homolog of E. coli recA required for recombination, synaptonemal complex formation, and cell cycle progression. Cell 1992, 69, 439–456. [Google Scholar] [CrossRef]
- Hollingsworth, N.M.; Ponte, L.; Halsey, C. MSH5, a novel MutS homolog, facilitates meiotic reciprocal recombination between homologs in Saccharomyces cerevisiae but not mismatch repair. Genes Dev. 1995, 9, 1728–1739. [Google Scholar] [CrossRef] [Green Version]
- Gray, S.; Cohen, P.E. Control of Meiotic Crossovers: From Double-Strand Break Formation to Designation. Annu. Rev. Genet. 2016, 50, 175–210. [Google Scholar] [CrossRef] [Green Version]
- Nguyen, Q.N.; Zerafa, N.; Liew, S.H.; Findlay, J.K.; Hickey, M.; Hutt, K.J. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes. Mol. Hum. Reprod. 2019, 25, 433–444. [Google Scholar] [CrossRef] [PubMed]
- Schreiber, V.; Dantzer, F.; Ame, J.C.; de Murcia, G. Poly(ADP-ribose): Novel functions for an old molecule. Nat. Rev. 2006, 7, 517–528. [Google Scholar] [CrossRef]
- Robson, M.; Im, S.A.; Senkus, E.; Xu, B.; Domchek, S.M.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Armstrong, A.; et al. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N. Engl. J. Med. 2017, 377, 523–533. [Google Scholar] [CrossRef] [PubMed]
- Winship, A.L.; Griffiths, M.; Lliberos Requesens, C.; Sarma, U.; Phillips, K.A.; Hutt, K.J. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: Implications for fertility preservation. Hum. Reprod. 2020, 35, 1864–1874. [Google Scholar] [CrossRef] [PubMed]
- Turan, V.; Oktay, K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum. Reprod. Update 2020, 26, 43–57. [Google Scholar] [CrossRef] [PubMed]
- Titus, S.; Li, F.; Stobezki, R.; Akula, K.; Unsal, E.; Jeong, K.; Dickler, M.; Robson, M.; Moy, F.; Goswami, S.; et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci. Transl. Med. 2013, 5, 172ra21. [Google Scholar] [CrossRef] [Green Version]
- Lin, W.; Titus, S.; Moy, F.; Ginsburg, E.S.; Oktay, K. Ovarian Aging in Women With BRCA Germline Mutations. J. Clin. Endocrinol. Metab. 2017, 102, 3839–3847. [Google Scholar] [CrossRef]
- Oktay, K.H.; Bedoschi, G.; Goldfarb, S.B.; Taylan, E.; Titus, S.; Palomaki, G.E.; Cigler, T.; Robson, M.; Dickler, M.N. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency. Fertil. Steril. 2020, 113, 1251–1260.e1. [Google Scholar] [CrossRef]
- Salian, S.R.; Uppangala, S.; Cheredath, A.; D’Souza, F.; Kalthur, G.; Nayak, V.C.; Anderson, R.A.; Adiga, S.K. Early prepubertal cyclophosphamide exposure in mice results in long-term loss of ovarian reserve, and impaired embryonic development and blastocyst quality. PLoS ONE 2020, 15, e0235140. [Google Scholar] [CrossRef]
- Meirow, D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma 1999, 33, 65–76. [Google Scholar] [CrossRef]
- Maltaris, T.; Weigel, M.; Mueller, A.; Schmidt, M.; Seufert, R.; Fischl, F.; Koelbl, H.; Dittrich, R. Cancer and fertility preservation: Fertility preservation in breast cancer patients. Breast Cancer Res. 2008, 10, 206. [Google Scholar] [CrossRef] [PubMed]
- Rossi, V.; Lispi, M.; Longobardi, S.; Mattei, M.; Di Rella, F.; Salustri, A.; De Felici, M.; Klinger, F.G. LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse. Cell Death Differ. 2017, 24, 72–82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xie, Y.; Li, S.; Zhou, L.; Lin, H.; Jiao, X.; Qiu, Q.; Liang, Y.; Zhang, Q. Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo. Mol. Reprod. Dev. 2020, 87, 442–453. [Google Scholar] [CrossRef] [PubMed]
- Ganesan, S.; Keating, A.F. The ovarian DNA damage repair response is induced prior to phosphoramide mustard-induced follicle depletion, and ataxia telangiectasia mutated inhibition prevents PM-induced follicle depletion. Toxicol. Appl. Pharm. 2016, 292, 65–74. [Google Scholar] [CrossRef]
- Amgalan, D.; Garner, T.P.; Pekson, R.; Jia, X.F.; Yanamandala, M.; Paulino, V.; Liang, F.G.; Corbalan, J.J.; Lee, J.; Chen, Y.; et al. A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy. Nat. Cancer 2020, 1, 315–328. [Google Scholar] [CrossRef]
- Garner, T.P.; Amgalan, D.; Reyna, D.E.; Li, S.; Kitsis, R.N.; Gavathiotis, E. Small-molecule allosteric inhibitors of BAX. Nat. Chem. Biol. 2019, 15, 322–330. [Google Scholar] [CrossRef]
- Kropp, J.; Roti Roti, E.C.; Ringelstetter, A.; Khatib, H.; Abbott, D.H.; Salih, S.M. Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice. PLoS ONE 2015, 10, e0142588. [Google Scholar] [CrossRef]
- Adriaens, I.; Smitz, J.; Jacquet, P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum. Reprod. Update 2009, 15, 359–377. [Google Scholar] [CrossRef] [Green Version]
- Massenkeil, G.; Alexander, T.; Rosen, O.; Dorken, B.; Burmester, G.; Radbruch, A.; Hiepe, F.; Arnold, R. Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation. Rheumatol. Int. 2016, 36, 1563–1568. [Google Scholar] [CrossRef]
- Oktem, O.; Oktay, K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007, 67, 10159–10162. [Google Scholar] [CrossRef] [Green Version]
- Soleimani, R.; Heytens, E.; Darzynkiewicz, Z.; Oktay, K. Mechanisms of chemotherapy-induced human ovarian aging: Double strand DNA breaks and microvascular compromise. Aging 2011, 3, 782–793. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gebel, J.; Tuppi, M.; Sänger, N.; Schumacher, B.; Dötsch, V. DNA Damaged Induced Cell Death in Oocytes. Molecules 2020, 25, 5714. https://doi.org/10.3390/molecules25235714
Gebel J, Tuppi M, Sänger N, Schumacher B, Dötsch V. DNA Damaged Induced Cell Death in Oocytes. Molecules. 2020; 25(23):5714. https://doi.org/10.3390/molecules25235714
Chicago/Turabian StyleGebel, Jakob, Marcel Tuppi, Nicole Sänger, Björn Schumacher, and Volker Dötsch. 2020. "DNA Damaged Induced Cell Death in Oocytes" Molecules 25, no. 23: 5714. https://doi.org/10.3390/molecules25235714